PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsHypromellose
Hypromellose
Hypromellose is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Searched
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
eye diseasesD005128
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
advanced eye relief/ redness maximum reliefC2002632024-09-25
alcon tears lubricant eye dropsC2002632023-12-14
artificial tearsOTC monograph final2019-10-28
auroviscC2002632024-01-27
aurovisc lubricant hypromellose 2208 (15000 mpa.s) gel/dropsC2002632024-01-12
aurovisc lubricant hypromellose 2208 (15000 mpa.s) solution/dropsOTC monograph final2023-01-11
biomedic artificial tearsExport only2023-03-17
bion tearsC2002632023-12-14
clear eyes complete 7 symptom reliefOTC monograph final2010-08-15
clear eyes complete 7 sympton reliefC2002632024-10-25
Show 51 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
S: Sensory organ drugs
S01: Ophthalmologicals
S01K: Surgical aids, ophthalmologic
S01KA: Viscoelastic substances
S01KA02: Hypromellose
HCPCS
No data
Clinical
Clinical Trials
503 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dry eye syndromesD015352H04.121119124074151
Keratoconjunctivitis siccaD007638EFO_1000906816112645102
Eye diseasesD005128EFO_0003966H44498112151
GlaucomaD005901EFO_0000516H4014312726
ConjunctivitisD003231HP_0000509H102313421
Meibomian gland dysfunctionD000080343H02.882251118
SyndromeD0135773722617
Healthy volunteers/patients811616
CataractD002386HP_0000518H26.916613
Allergic conjunctivitisD003233EFO_0007141H10.4411213
Show 62 more
Indications Phases 2
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Muscle strengthD05358044
Resistance trainingD05507033
Body compositionD00182333
Diabetes mellitusD003920HP_0000819E08-E1333
Skin diseasesD012871L00-L9922
DermatitisD003872HP_0011123L30.922
InfertilityD007246HP_000078922
Corneal injuriesD065306HP_000055922
Alopecia areataD000506EFO_0004192L6322
AlopeciaD000505HP_0002293L6422
Show 58 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameHypromellose
INNhypromellose
Description
Hypromellose (INN), short for hydroxypropyl methylcellulose (HPMC), is a semisynthetic, inert, viscoelastic polymer used in eye drops, as well as an excipient and controlled-delivery component in oral medicaments, found in a variety of commercial products.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL2108956
ChEBI ID
PubChem CID
DrugBank
UNII ID0HO1H52958 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 10,730 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,857 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use